Skip to main content Skip to footer
HomeHome
 
  • Homepage
  • Searching for patents

    Patent knowledge

    Access our patent databases and search tools.

    Go to overview 

    • Overview
    • Technical information
      • Overview
      • Espacenet - patent search
      • European Publication Server
      • EP full-text search
    • Legal information
      • Overview
      • European Patent Register
      • European Patent Bulletin
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Overview
      • PATSTAT
      • IPscore
      • Technology insight reports
    • Data
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
      • Web services
      • Coverage, codes and statistics
    • Technology platforms
      • Overview
      • Plastics in transition
      • Water innovation
      • Space innovation
      • Technologies combatting cancer
      • Firefighting technologies
      • Clean energy technologies
      • Fighting coronavirus
    • Helpful resources
      • Overview
      • First time here?
      • Asian patent information
      • Patent information centres
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
    Image
    Plastics in Transition

    Technology insight report on plastic waste management

  • Applying for a patent

    Applying for a patent

    Practical information on filing and grant procedures.

    Go to overview 

    • Overview
    • European route
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
      • Appeals
      • Unitary Patent & Unified Patent Court
      • National validation
      • Request for extension/validation
    • International route (PCT)
      • Overview
      • Euro-PCT Guide – PCT procedure at the EPO
      • EPO decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
      • Training and events
    • National route
    • Find a professional representative
    • MyEPO services
      • Overview
      • Understand our services
      • Get access
      • File with us
      • Interact with us on your files
      • Online Filing & fee payment outages
    • Forms
      • Overview
      • Request for examination
    • Fees
      • Overview
      • European fees (EPC)
      • International fees (PCT)
      • Unitary Patent fees (UP)
      • Fee payment and refunds
      • Warning

    UP

    Find out how the Unitary Patent can enhance your IP strategy

  • Law & practice

    Law & practice

    European patent law, the Official Journal and other legal texts.

    Go to overview 

    • Overview
    • Legal texts
      • Overview
      • European Patent Convention
      • Official Journal
      • Guidelines
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
      • Unitary patent system
      • National measures relating to the Unitary Patent
    • Court practices
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
    Image
    Law and practice scales 720x237

    Keep up with key aspects of selected BoA decisions with our monthly "Abstracts of decisions”

  • News & events

    News & events

    Our latest news, podcasts and events, including the European Inventor Award.

    Go to overview 

     

    • Overview
    • News
    • Events
    • European Inventor Award
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the finalists
      • Nominations
      • European Inventor Network
      • The 2024 event
    • Young Inventor Prize
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
    • Press centre
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • Innovation and patenting in focus
      • Overview
      • Water-related technologies
      • CodeFest
      • Green tech in focus
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
      • The future of medicine
      • Materials science
      • Mobile communications
      • Biotechnology
      • Patent classification
      • Digital technologies
      • The future of manufacturing
      • Books by EPO experts
    • "Talk innovation" podcast

    Podcast

    From ideas to inventions: tune into our podcast for the latest in tech and IP

  • Learning

    Learning

    The European Patent Academy – the point of access to your learning

    Go to overview 

    • Overview
    • Learning activities and paths
      • Overview
      • Learning activities
      • Learning paths
    • EQE and EPAC
      • Overview
      • EQE - European qualifying examination
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Overview
      • Business and IP managers
      • EQE and EPAC Candidates
      • Judges, lawyers and prosecutors
      • National offices and IP authorities
      • Patent attorneys and paralegals
      • Universities, research centres and technology transfer centres (TTOs)
    Image
    Patent Academy catalogue

    Have a look at the extensive range of learning opportunities in the European Patent Academy training catalogue

  • About us

    About us

    Find out more about our work, values, history and vision

    Go to overview 

    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Overview
      • Official celebrations
      • Member states’ video statements
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Overview
      • Legal foundations
      • Member states of the European Patent Organisation
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Overview
      • Communiqués
      • Calendar
      • Documents and publications
      • Administrative Council
    • Principles & strategy
      • Overview
      • Our mission, vision, values and corporate policy
      • Strategic Plan 2028
      • Towards a New Normal
    • Leadership & management
      • Overview
      • President António Campinos
      • Management Advisory Committee
    • Sustainability at the EPO
      • Overview
      • Environmental
      • Social
      • Governance and Financial sustainability
    • Services & activities
      • Overview
      • Our services & structure
      • Quality
      • Consulting our users
      • European and international co-operation
      • European Patent Academy
      • Chief Economist
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Overview
      • Innovation actors
      • Policy and funding
      • Tools
      • About the Observatory
    • Procurement
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Sustainable Procurement Policy
      • About eTendering and electronic signatures
      • Procurement portal
      • Invoicing
      • General conditions
      • Archived tenders
    • Transparency portal
      • Overview
      • General
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
      • "Long Night"
    Image
    Patent Index 2024 keyvisual showing brightly lit up data chip, tinted in purple, bright blue

    Track the latest tech trends with our Patent Index

 
en de fr
  • Language selection
  • English
  • Deutsch
  • Français
Main navigation
  • Homepage
    • Go back
    • New to patents
  • New to patents
    • Go back
    • Your business and patents
    • Why do we have patents?
    • What's your big idea?
    • Are you ready?
    • What to expect
    • How to apply for a patent
    • Is it patentable?
    • Are you first?
    • Patent quiz
    • Unitary patent video
  • Searching for patents
    • Go back
    • Overview
    • Technical information
      • Go back
      • Overview
      • Espacenet - patent search
        • Go back
        • Overview
        • National patent office databases
        • Global Patent Index (GPI)
        • Release notes
      • European Publication Server
        • Go back
        • Overview
        • Release notes
        • Cross-reference index for Euro-PCT applications
        • EP authority file
        • Help
      • EP full-text search
    • Legal information
      • Go back
      • Overview
      • European Patent Register
        • Go back
        • Overview
        • Release notes archive
        • Register documentation
          • Go back
          • Overview
          • Deep link data coverage
          • Federated Register
          • Register events
      • European Patent Bulletin
        • Go back
        • Overview
        • Download Bulletin
        • EP Bulletin search
        • Help
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Go back
      • Overview
      • PATSTAT
      • IPscore
        • Go back
        • Release notes
      • Technology insight reports
    • Data
      • Go back
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
        • Go back
        • Overview
        • Manuals
        • Sequence listings
        • National full-text data
        • European Patent Register data
        • EPO worldwide bibliographic data (DOCDB)
        • EP full-text data
        • EPO worldwide legal event data (INPADOC)
        • EP bibliographic data (EBD)
        • Boards of Appeal decisions
      • Web services
        • Go back
        • Overview
        • Open Patent Services (OPS)
        • European Publication Server web service
      • Coverage, codes and statistics
        • Go back
        • Weekly updates
        • Updated regularly
    • Technology platforms
      • Go back
      • Overview
      • Plastics in transition
        • Go back
        • Overview
        • Plastics waste recovery
        • Plastics waste recycling
        • Alternative plastics
      • Innovation in water technologies
        • Go back
        • Overview
        • Clean water
        • Protection from water
      • Space innovation
        • Go back
        • Overview
        • Cosmonautics
        • Space observation
      • Technologies combatting cancer
        • Go back
        • Overview
        • Prevention and early detection
        • Diagnostics
        • Therapies
        • Wellbeing and aftercare
      • Firefighting technologies
        • Go back
        • Overview
        • Detection and prevention of fires
        • Fire extinguishing
        • Protective equipment
        • Post-fire restoration
      • Clean energy technologies
        • Go back
        • Overview
        • Renewable energy
        • Carbon-intensive industries
        • Energy storage and other enabling technologies
      • Fighting coronavirus
        • Go back
        • Overview
        • Vaccines and therapeutics
          • Go back
          • Overview
          • Vaccines
          • Overview of candidate therapies for COVID-19
          • Candidate antiviral and symptomatic therapeutics
          • Nucleic acids and antibodies to fight coronavirus
        • Diagnostics and analytics
          • Go back
          • Overview
          • Protein and nucleic acid assays
          • Analytical protocols
        • Informatics
          • Go back
          • Overview
          • Bioinformatics
          • Healthcare informatics
        • Technologies for the new normal
          • Go back
          • Overview
          • Devices, materials and equipment
          • Procedures, actions and activities
          • Digital technologies
        • Inventors against coronavirus
    • Helpful resources
      • Go back
      • Overview
      • First time here?
        • Go back
        • Overview
        • Basic definitions
        • Patent classification
          • Go back
          • Overview
          • Cooperative Patent Classification (CPC)
        • Patent families
          • Go back
          • Overview
          • DOCDB simple patent family
          • INPADOC extended patent family
        • Legal event data
          • Go back
          • Overview
          • INPADOC classification scheme
      • Asian patent information
        • Go back
        • Overview
        • China (CN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Chinese Taipei (TW)
          • Go back
          • Overview
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • India (IN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
        • Japan (JP)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Korea (KR)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Russian Federation (RU)
          • Go back
          • Overview
          • Facts and figures
          • Numbering system
          • Searching in databases
        • Useful links
      • Patent information centres (PATLIB)
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
  • Applying for a patent
    • Go back
    • Overview
    • European route
      • Go back
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
        • Go back
        • Oral proceedings calendar
          • Go back
          • Calendar
          • Public access to appeal proceedings
          • Public access to opposition proceedings
          • Technical guidelines
      • Appeals
      • Unitary Patent & Unified Patent Court
        • Go back
        • Overview
        • Unitary Patent
          • Go back
          • Overview
          • Legal framework
          • Main features
          • Applying for a Unitary Patent
          • Cost of a Unitary Patent
          • Translation and compensation
          • Start date
          • Introductory brochures
        • Unified Patent Court
      • National validation
      • Extension/validation request
    • International route
      • Go back
      • Overview
      • Euro-PCT Guide
      • Entry into the European phase
      • Decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
        • Go back
        • Patent Prosecution Highway (PPH) programme outline
      • Training and events
    • National route
    • MyEPO services
      • Go back
      • Overview
      • Understand our services
        • Go back
        • Overview
        • Exchange data with us using an API
          • Go back
          • Release notes
      • Get access
        • Go back
        • Overview
        • Release notes
      • File with us
        • Go back
        • Overview
        • What if our online filing services are down?
        • Release notes
      • Interact with us on your files
        • Go back
        • Release notes
      • Online Filing & fee payment outages
    • Fees
      • Go back
      • Overview
      • European fees (EPC)
        • Go back
        • Overview
        • Decisions and notices
      • International fees (PCT)
        • Go back
        • Reduction in fees
        • Fees for international applications
        • Decisions and notices
        • Overview
      • Unitary Patent fees (UP)
        • Go back
        • Overview
        • Decisions and notices
      • Fee payment and refunds
        • Go back
        • Overview
        • Payment methods
        • Getting started
        • FAQs and other documentation
        • Technical information for batch payments
        • Decisions and notices
        • Release notes
      • Warning
    • Forms
      • Go back
      • Overview
      • Request for examination
    • Find a professional representative
  • Law & practice
    • Go back
    • Overview
    • Legal texts
      • Go back
      • Overview
      • European Patent Convention
        • Go back
        • Overview
        • Archive
          • Go back
          • Overview
          • Documentation on the EPC revision 2000
            • Go back
            • Overview
            • Diplomatic Conference for the revision of the EPC
            • Travaux préparatoires
            • New text
            • Transitional provisions
            • Implementing regulations to the EPC 2000
            • Rules relating to Fees
            • Ratifications and accessions
          • Travaux Préparatoires EPC 1973
      • Official Journal
      • Guidelines
        • Go back
        • Overview
        • EPC Guidelines
        • PCT-EPO Guidelines
        • Unitary Patent Guidelines
        • Guidelines revision cycle
        • Consultation results
        • Summary of user responses
        • Archive
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
        • Go back
        • Overview
        • Archive
      • Unitary Patent system
        • Go back
        • Travaux préparatoires to UP and UPC
      • National measures relating to the Unitary Patent 
    • Court practices
      • Go back
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Go back
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Go back
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
  • News & events
    • Go back
    • Overview
    • News
    • Events
    • European Inventor Award
      • Go back
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the inventors
      • Nominations
      • European Inventor Network
        • Go back
        • 2024 activities
        • 2025 activities
        • Rules and criteria
        • FAQ
      • The 2024 event
    • Young Inventors Prize
      • Go back
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
      • The 2025 event
    • Press centre
      • Go back
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
        • Go back
        • Overview
        • European Patent Office
        • Q&A on patents related to coronavirus
        • Q&A on plant patents
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • In focus
      • Go back
      • Overview
      • Water-related technologies
      • CodeFest
        • Go back
        • CodeFest Spring 2025 on classifying patent data for sustainable development
        • Overview
        • CodeFest 2024 on generative AI
        • CodeFest 2023 on Green Plastics
      • Green tech in focus
        • Go back
        • Overview
        • About green tech
        • Renewable energies
        • Energy transition technologies
        • Building a greener future
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
        • Go back
        • Overview
        • Patents and space technologies
      • Healthcare
        • Go back
        • Overview
        • Medical technologies and cancer
        • Personalised medicine
      • Materials science
        • Go back
        • Overview
        • Nanotechnology
      • Mobile communications
      • Biotechnology
        • Go back
        • Overview
        • Red, white or green
        • The role of the EPO
        • What is patentable?
        • Biotech inventors
      • Classification
        • Go back
        • Overview
        • Nanotechnology
        • Climate change mitigation technologies
          • Go back
          • Overview
          • External partners
          • Updates on Y02 and Y04S
      • Digital technologies
        • Go back
        • Overview
        • About ICT
        • Hardware and software
        • Artificial intelligence
        • Fourth Industrial Revolution
      • Additive manufacturing
        • Go back
        • Overview
        • About AM
        • AM innovation
      • Books by EPO experts
    • Podcast
  • Learning
    • Go back
    • Overview
    • Learning activities and paths
      • Go back
      • Overview
      • Learning activities: types and formats
      • Learning paths
    • EQE and EPAC
      • Go back
      • Overview
      • EQE - European Qualifying Examination
        • Go back
        • Overview
        • Compendium
          • Go back
          • Overview
          • Paper F
          • Paper A
          • Paper B
          • Paper C
          • Paper D
          • Pre-examination
        • Candidates successful in the European qualifying examination
        • Archive
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Go back
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Go back
      • Overview
      • Business and IP managers
        • Go back
        • Overview
        • Innovation case studies
          • Go back
          • Overview
          • SME case studies
          • Technology transfer case studies
          • High-growth technology case studies
        • Inventor's handbook
          • Go back
          • Overview
          • Introduction
          • Disclosure and confidentiality
          • Novelty and prior art
          • Competition and market potential
          • Assessing the risk ahead
          • Proving the invention
          • Protecting your idea
          • Building a team and seeking funding
          • Business planning
          • Finding and approaching companies
          • Dealing with companies
        • Best of search matters
          • Go back
          • Overview
          • Tools and databases
          • EPO procedures and initiatives
          • Search strategies
          • Challenges and specific topics
        • Support for high-growth technology businesses
          • Go back
          • Overview
          • Business decision-makers
          • IP professionals
          • Stakeholders of the Innovation Ecosystem
      • EQE and EPAC Candidates
        • Go back
        • Overview
        • Paper F brain-teasers
        • Daily D questions
        • European qualifying examination - Guide for preparation
        • EPAC
      • Judges, lawyers and prosecutors
        • Go back
        • Overview
        • Compulsory licensing in Europe
        • The jurisdiction of European courts in patent disputes
      • National offices and IP authorities
        • Go back
        • Overview
        • Learning material for examiners of national officers
        • Learning material for formalities officers and paralegals
      • Patent attorneys and paralegals
      • Universities, research centres and TTOs
        • Go back
        • Overview
        • Modular IP Education Framework (MIPEF)
        • Pan-European Seal Young Professionals Programme
          • Go back
          • Overview
          • For students
          • For universities
            • Go back
            • Overview
            • IP education resources
            • University memberships
          • Our young professionals
          • Professional development plan
        • Academic Research Programme
          • Go back
          • Overview
          • Completed research projects
          • Current research projects
        • IP Teaching Kit
          • Go back
          • Overview
          • Download modules
        • Intellectual property course design manual
        • PATLIB Knowledge Transfer to Africa
          • Go back
          • The PATLIB Knowledge Transfer to Africa initiative (KT2A)
          • KT2A core activities
          • Success story: Malawi University of Science and Technology and PATLIB Birmingham
  • About us
    • Go back
    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Go back
      • Official celebrations
      • Overview
      • Member states’ video statements
        • Go back
        • Albania
        • Austria
        • Belgium
        • Bulgaria
        • Croatia
        • Cyprus
        • Czech Republic
        • Denmark
        • Estonia
        • Finland
        • France
        • Germany
        • Greece
        • Hungary
        • Iceland
        • Ireland
        • Italy
        • Latvia
        • Liechtenstein
        • Lithuania
        • Luxembourg
        • Malta
        • Monaco
        • Montenegro
        • Netherlands
        • North Macedonia
        • Norway
        • Poland
        • Portugal
        • Romania
        • San Marino
        • Serbia
        • Slovakia
        • Slovenia
        • Spain
        • Sweden
        • Switzerland
        • Türkiye
        • United Kingdom
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Go back
      • Overview
      • Legal foundations
      • Member states
        • Go back
        • Overview
        • Member states by date of accession
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Go back
      • Overview
      • Communiqués
        • Go back
        • 2024
        • Overview
        • 2023
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
        • 2013
      • Calendar
      • Documents and publications
        • Go back
        • Overview
        • Select Committee documents
      • Administrative Council
        • Go back
        • Overview
        • Composition
        • Representatives
        • Rules of Procedure
        • Board of Auditors
        • Secretariat
        • Council bodies
    • Principles & strategy
      • Go back
      • Overview
      • Mission, vision, values & corporate policy
      • Strategic Plan 2028
        • Go back
        • Driver 1: People
        • Driver 2: Technologies
        • Driver 3: High-quality, timely products and services
        • Driver 4: Partnerships
        • Driver 5: Financial sustainability
      • Towards a New Normal
      • Data protection & privacy notice
    • Leadership & management
      • Go back
      • Overview
      • About the President
      • Management Advisory Committee
    • Sustainability at the EPO
      • Go back
      • Overview
      • Environmental
        • Go back
        • Overview
        • Inspiring environmental inventions
      • Social
        • Go back
        • Overview
        • Inspiring social inventions
      • Governance and Financial sustainability
    • Procurement
      • Go back
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Dynamic Purchasing System (DPS) publications
      • Sustainable Procurement Policy
      • About eTendering
      • Invoicing
      • Procurement portal
        • Go back
        • Overview
        • e-Signing contracts
      • General conditions
      • Archived tenders
    • Services & activities
      • Go back
      • Overview
      • Our services & structure
      • Quality
        • Go back
        • Overview
        • Foundations
          • Go back
          • Overview
          • European Patent Convention
          • Guidelines for examination
          • Our staff
        • Enabling quality
          • Go back
          • Overview
          • Prior art
          • Classification
          • Tools
          • Processes
        • Products & services
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
          • Continuous improvement
        • Quality through networking
          • Go back
          • Overview
          • User engagement
          • Co-operation
          • User satisfaction survey
          • Stakeholder Quality Assurance Panels
        • Patent Quality Charter
        • Quality Action Plan
        • Quality dashboard
        • Statistics
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
        • Integrated management at the EPO
      • Consulting our users
        • Go back
        • Overview
        • Standing Advisory Committee before the EPO (SACEPO)
          • Go back
          • Overview
          • Objectives
          • SACEPO and its working parties
          • Meetings
          • Single Access Portal – SACEPO Area
        • Surveys
          • Go back
          • Overview
          • Detailed methodology
          • Search services
          • Examination services, final actions and publication
          • Opposition services
          • Formalities services
          • Customer services
          • Filing services
          • Key Account Management (KAM)
          • Website
          • Archive
      • Our user service charter
      • European and international co-operation
        • Go back
        • Overview
        • Co-operation with member states
          • Go back
          • Overview
        • Bilateral co-operation with non-member states
          • Go back
          • Overview
          • Validation system
          • Reinforced Partnership programme
        • Multilateral international co-operation with IP offices and organisations
        • Co-operation with international organisations outside the IP system
      • European Patent Academy
        • Go back
        • Overview
        • Partners
      • Chief Economist
        • Go back
        • Overview
        • Economic studies
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Go back
      • Overview
      • Innovation against cancer
      • Innovation actors
        • Go back
        • Overview
        • Startups and SMEs
      • Policy and funding
        • Go back
        • Overview
        • Financing innovation programme
          • Go back
          • Overview
          • Our studies on the financing of innovation
          • EPO initiatives for patent applicants
          • Financial support for innovators in Europe
        • Patents and standards
          • Go back
          • Overview
          • Publications
          • Patent standards explorer
      • Tools
        • Go back
        • Overview
        • Deep Tech Finder
      • About the Observatory
        • Go back
        • Overview
        • Work plan
    • Transparency portal
      • Go back
      • Overview
      • General
        • Go back
        • Overview
        • Annual Review 2023
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • 50 years of the EPC
          • Strategic key performance indicators
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
        • Annual Review 2022
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Go back
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
        • Go back
        • Insight into computer technology and AI
        • Insight into clean energy technologies
        • Statistics and indicators
          • Go back
          • European patent applications
            • Go back
            • Key trend
            • Origin
            • Top 10 technical fields
              • Go back
              • Computer technology
              • Electrical machinery, apparatus, energy
              • Digital communication
              • Medical technology
              • Transport
              • Measurement
              • Biotechnology
              • Pharmaceuticals
              • Other special machines
              • Organic fine chemistry
            • All technical fields
          • Applicants
            • Go back
            • Top 50
            • Categories
            • Women inventors
          • Granted patents
            • Go back
            • Key trend
            • Origin
            • Designations
      • Data to download
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Go back
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Go back
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
        • Go back
        • Catalyst lab & Deep vision
          • Go back
          • Irene Sauter (DE)
          • AVPD (DK)
          • Jan Robert Leegte (NL)
          • Jānis Dzirnieks (LV) #1
          • Jānis Dzirnieks (LV) #2
          • Péter Szalay (HU)
          • Thomas Feuerstein (AT)
          • Tom Burr (US)
          • Wolfgang Tillmans (DE)
          • TerraPort
          • Unfinished Sculpture - Captives #1
          • Deep vision – immersive exhibition
          • Previous exhibitions
        • The European Patent Journey
        • Sustaining life. Art in the climate emergency
        • Next generation statements
        • Open storage
        • Cosmic bar
      • "Long Night"
  • Boards of Appeal
    • Go back
    • Overview
    • Decisions of the Boards of Appeal
      • Go back
      • Overview
      • Recent decisions
      • Selected decisions
    • Information from the Boards of Appeal
    • Procedure
    • Oral proceedings
    • About the Boards of Appeal
      • Go back
      • Overview
      • President of the Boards of Appeal
      • Enlarged Board of Appeal
        • Go back
        • Overview
        • Pending referrals (Art. 112 EPC)
        • Decisions sorted by number (Art. 112 EPC)
        • Pending petitions for review (Art. 112a EPC)
        • Decisions on petitions for review (Art. 112a EPC)
      • Technical Boards of Appeal
      • Legal Board of Appeal
      • Disciplinary Board of Appeal
      • Presidium
        • Go back
        • Overview
    • Code of Conduct
    • Business distribution scheme
      • Go back
      • Overview
      • Technical boards of appeal by IPC in 2025
      • Archive
    • Annual list of cases
    • Communications
    • Annual reports
      • Go back
      • Overview
    • Publications
      • Go back
      • Abstracts of decisions
    • Case Law of the Boards of Appeal
      • Go back
      • Overview
      • Archive
  • Service & support
    • Go back
    • Overview
    • Website updates
    • Availability of online services
      • Go back
      • Overview
    • FAQ
      • Go back
      • Overview
    • Publications
    • Ordering
      • Go back
      • Overview
      • Patent Knowledge Products and Services
      • Terms and conditions
        • Go back
        • Overview
        • Patent information products
        • Bulk data sets
        • Open Patent Services (OPS)
        • Fair use charter
    • Procedural communications
    • Useful links
      • Go back
      • Overview
      • Patent offices of member states
      • Other patent offices
      • Directories of patent attorneys
      • Patent databases, registers and gazettes
      • Disclaimer
    • Contact us
      • Go back
      • Overview
      • Filing options
      • Locations
    • Subscription centre
      • Go back
      • Overview
      • Subscribe
      • Change preferences
      • Unsubscribe
    • Official holidays
    • Glossary
    • RSS feeds
Board of Appeals
Decisions

Recent decisions

Overview
  • 2025 decisions
  • 2024 decisions
  • 2023 decisions
  1. Home
  2. T 0764/06 (Crystalline form of atorvastatin/WARNER-LAMBERT COMPANY LLC) 25-02-2009
Facebook X Linkedin Email

T 0764/06 (Crystalline form of atorvastatin/WARNER-LAMBERT COMPANY LLC) 25-02-2009

European Case Law Identifier
ECLI:EP:BA:2009:T076406.20090225
Date of decision
25 February 2009
Case number
T 0764/06
Petition for review of
-
Application number
96924368.2
IPC class
C07D 207/34
Language of proceedings
EN
Distribution
DISTRIBUTED TO BOARD CHAIRMEN (C)

Download and more information:

Decision in EN 115.94 KB
Documentation of the appeal procedure can be found in the European Patent Register
Bibliographic information is available in:
EN
Versions
Unpublished
Application title

Crystalline R-(R*,R*)-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-(phenylamino)carbonyl-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)

Applicant name
Warner-Lambert Company LLC
Opponent name

Teva Pharmaceutical Industries Ltd.

LEK Pharmaceutical and Chemical Company d.d.

Board
3.3.01
Headnote
-
Relevant legal provisions
European Patent Convention Art 123(2)
European Patent Convention Art 114(2) 1973
European Patent Convention Art 113(1) 1973
European Patent Convention Art 100(c) 1973
Rules of procedure of the Boards of Appeal Art 13(1)
Rules of procedure of the Boards of Appeal Art 13(3)
European Patent Convention R 55(c) 1973
European Patent Convention R 76(c)
Keywords

Admissibility of allegedly new ground of opposition (yes)

Added matter (yes) - Omission of an essential feature

Late-filed request (not admitted)

Catchword
-
Cited decisions
G 0007/95
G 0001/95
G 0010/91
G 0009/91
T 0746/99
T 0128/98
T 1180/97
T 0114/95
T 0926/93
T 0737/92
Citing decisions
R 0007/14
T 2016/11

I. Opponent II and the patent proprietor both appealed against the decision of the opposition division that maintained the European patent No. 0 848 705 as amended according to the only auxiliary request filed on 20 January 2006 and the adapted description meeting the requirements of the EPC. The patent proprietor withdrew his appeal during the oral proceedings before the board.

Claim 1 according to that auxiliary request read as follows:

"1. Crystalline Form I atorvastatin (i.e.[R-(R*,R*)]-2-(4fluorophenyl)-ß,delta-dihydroxy-5- (1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1- heptanoic acid hemi calcium salt) hydrate, having an X-ray powder diffraction pattern containing the following 2Theta values measured using CuKalpha radiation 9.150, 9.470, 10.266 10.560, 11.853, 12.195, 17.075, 19.485, 21.626, 21.960, 22.748, 23.335, 23.734, 24.438, 28.915, 29.234."

II. Claims 1 and 4 as granted read as follows:

"1. Crystalline Form I atorvastatin (i.e.[R-(R*,R*)]-2-(4fluorophenyl)-ß,delta-dihydroxy-5- (1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1- heptanoic acid hemi calcium salt) hydrate, having an X-ray powder diffraction pattern containing the following 2Theta values measured using CuKalpha radiation: 19.485 and 21.626."

"4. Crystalline Form I atorvastatin hydrate, having an X-ray powder diffraction pattern containing the following 2Theta values measured using CuKalpha radiation: 9.150, 9.470, 10.266, 10.560, 11.853, 12.195, 17.075, 19.485, 21.626, 21.960, 22.748, 23.335, 23.734, 24.438, 28.915, 29.234."

III. The oppositions filed by the three opponents I, II and III sought revocation of the patent in suit in its entirety. Opponents I and III had raised, in particular, an objection under Article 100 (c) EPC (the latter later withdrew his opposition). The opposition division held, however, that the subject-matter of the auxiliary request fulfilled the requirements of Article 123(2) EPC.

IV. The appellant argued inter alia that the subject-matter of claim 1 (see point 1 above) gave rise to an objection under Article 100 (c) EPC, because, the 2-theta values mentioned in claim 1 were not associated with their relative intensity values as set out in the description as originally filed. Therefore, even very small intensities were encompassed within the claimed scope. However, the application as filed was limited to relative intensities of >20% (see Tables on pages 4 and 13 and claim 1) so that these relative intensity values represented indispensable characteristics. Their omission led, thus, to a subject-matter extending beyond the disclosure of the application as originally filed.

Furthermore, the amended set of claims submitted during oral proceedings held on 25 February 2009 should not be admitted because late filed.

V. Opponent I (Respondent II), who neither filed an appeal nor intervened in writing, was present at the oral proceedings and declared that he did not have any specific request.

VI. Respondent I (patent proprietor, hereafter "Respondent") considered that the objection based on Article 100(c) EPC should not be admitted in view of Article 114(2) EPC and the constant jurisprudence of the boards of appeals, in particular decisions T 746/99; T 128/98; T 737/92; G 9/91 and G 10/91). Furthermore, before the opposition division no objection had been raised against claim 1 (identical to claim 4 as granted and found to meet the requirements of the EPC) and this claim was not examined by the opposition division on the basis of Article 100 (c) EPC.

Furthermore, the respondent contested the appellant's argument with respect to the relative intensity values, because these values could not be considered as structural parameters of the claimed compounds as admitted by the opponents in their written submissions before the opposition division and confirmed by the following documents:

(3) US Pharmacopeia 23, pages 1843-1844

(4) Pharmeuropa, vol. 14, No. 1, January 2002, pages 185-191

(7) Jenkins R. and Snyder R.I., "Introduction to X-Ray Powder Diffractometry", (1996), John Wiley & Sons, Inc., pages 358,238,239.

The relative intensity of each peak is dependent on several parameters and the values can change as illustrated by document (3) (see page 1843, right-hand column, third paragraph from the bottom) and document (7) (see first paragraph on page 358). Moreover, the relative intensity values are used to compare an unknown crystal with a known reference as shown in document (3) (see page 1844, beginning of the last paragraph) and document (4) (see pages 189-190 bridging paragraph). In contrast, in the patent in suit the structure of the compound has already been described.

The filing of a new set of claims during oral proceedings after the board had announced that claim 1 gave rise to an objection under Article 100 (c) EPC was justified by the fact that no hint had been given by the board during the written procedure that the admissibility of the ground of appeal pursuant Article 100(c) EPC would be discussed during the oral proceedings, this point not having been discussed in the opposition proceedings either.

Furthermore, up to then relative intensity values had not been considered an essential parameter to characterize the crystalline form claimed in claim 1.

VII. The appellant requested that the interlocutory decision of the opposition division be set aside and the patent in suit be revoked.

The respondent requested that the appeal be dismissed.

VIII. At the end of the oral proceedings, the decision of the board was announced.

1. The appeal is admissible

2. Claim 1 found to be allowable in the decision under appeal corresponds to claim 4 as granted (see points I and II above).

Admissibility of the ground of opposition pursuant to Article 100(c)EPC

3. The respondent maintained that this ground for opposition should be disregarded on the ground that it had not been raised by any of the opponents against the claims 4, 6 and 9 as granted, now claims 1, 6 and 9 and it had not been examined by the opposition division. As it had not been in dispute during the opposition proceedings said ground for opposition was not admissible on appeal.

In support of this position the respondent relied on decisions T 737/92, T 128/98, T 746/99, G 9/91 and 10/91, which he contended represented the relevant constant jurisprudence of the boards of appeal.

3.1 Rule 55(c) EPC 1973, now Rule 76(c) EPC, does not refer to claims but rather requires that the notice of opposition contains a statement of the extent to which the patent was opposed. Where an opponent - as in the present case - requested revocation of the patent in its entirety, for the requirements of said Rule, which include the grounds on which the opposition is based, to be met, it is sufficient to substantiate the ground(s) for opposition in respect of at least one claim of the patent. If one claim of each request is found not to be allowable, the patent will be revoked. Thus an opponent is under no obligation to substantiate grounds of opposition against more than one claim of such request (decisions T 926/93, OJ EPO 447, T 114/95, and T 1180/97). Furthermore, it was held in decision T 114/95 that there was no limitation set by the EPC on allowing an opponent, whose opposition was considered admissible, to support and use grounds, evidence and arguments for revocation of the patent that were submitted by other opponents.

3.2 The decisions of the boards of appeal cited by the appellant are not relevant and, in any event, not in conflict with the jurisprudence set out above: Decision T 737/92 concerned the situation where the ground of opposition pursuant Article 100(c) was not substantiated at all. In the case underlying Decision T 128/98 an objection based on Article 100(c) EPC was raised for the first time in the statement setting out the grounds of appeal. In decision T 746/99 it was lack of novelty which had not been in dispute during opposition proceedings, which ground of opposition was then held not admissible on appeal.

3.3 The patent in suit was opposed in its entirety by all opponents, either explicitly or implicitly, as none of them had made a statement under Rule 55(c) EPC 1973 that the patent was opposed only to a certain extent (see Point 8 of the decision G 9/91, OJ EPO 1993,408 and G 10/91, both cited by the appellant, but equally of no relevance for the specific matter at issue, in that both deal in essence with the restriction of the examination of an opposition to the grounds raised in the notice of opposition).

As to the substantiation of the ground of opposition in question, this requirement (see decisions G 1/95 and G 7/95, OJ EPO 1996, 615 and 626) was undisputedly also fulfilled at least by one opponent (e.g. "III. Unzulässige Erweiterung gemäss Artikel 123(2) EPÜ" on pages 5 - 8 of the notice of appeal of opponent I).

3.4 It follows, that in the present case the ground for opposition under Article 100(c) EPC did not constitute a fresh ground for opposition and, therefore, its consideration by the board of appeal did not require the appellant's (patentee's) approval (see decision G 10/91).

3.5 From the fact that none of the opponents objected to the allowability of auxiliary request 1 in view of the requirements of Article 123(2) EPC as mentioned in the decision of the opposition division, and no argument was put forward against claim 1 (claim 4 of the granted version) during opposition procedure, it cannot, contrary to the appellant's contention, be derived that the ground of opposition pursuant to Article 100(c) EPC was not in dispute during opposition procedure. The absence of any allegation of extension of the subject matter of the claims according to the auxiliary request during opposition procedure can very well be due to a deliberate choice of the opponents to dispute the patentability of the subject matter of this request on other grounds. Rather, a ground of opposition, once it has been validly raised, continues to belong to the legal and factual framework of the opposition according to Rule 76(c) EPC (see point 3.3 above).

3.6 The ground of opposition based on Article 100(c) EPC is therefore admissible. Its consideration does not require the respondent's approval.

4. Article 100(c) EPC

4.1 In claim 1 as originally filed, each 2Theta values of X-ray diffraction peaks for the crystalline form I of the atorvastatin is shown together with its relative intensity (> 20%) after two minutes of grinding of the different peaks. In present claim 1, the same 2Theta values appear, however without the respective relative intensity value of each peak (see point I above). It should thus be investigated, whether the person skilled in the art using his common general knowledge would derive directly and unambiguously from the description as filed that the diffraction values are not necessarily disclosed in association with their respective relative intensity values as currently claimed in claim 1.

4.2 The table in claim 1 as originally filed is supported by the description as originally filed (see page 4). The paragraph introducing said table in the description reads as follows:

"Accordingly, the present invention is directed to crystalline Form I atorvastatin and hydrates thereof characterized by the following X-ray powder diffraction pattern expressed in terms of the 2Theta, d-spacings, and relative intensities with a relative intensity of > 20% measured after 2 minutes of grinding and measured on a Siemens D-500 diffractometer with CuKalpha radiation:"

4.3 Therefore, the person skilled in the art has to rely on the content of the description as originally filed in order to decide thereon. On page 3 of this description, under "Summary of the invention", the subject-matter to which the invention is directed is mentioned. In this definition the diffraction values (peaks or d-spacings) are disclosed together with the relative intensity values of each peak. Also in the other parts of the description these diffraction values are always disclosed together with their relative intensity values (see point 4.1). The person skilled in the art would thus conclude that the latter are essential to characterize the claimed subject-matter.

4.4 The board notes that opponent I himself pointed out in his statement setting out the grounds of opposition that the intensity varies depending on the orientation of the crystal under analysis (see page 10, paragraph 2). Opponent III maintained that the intensity of the peaks is not a parameter of the compound (see page 7 of the statement of grounds of opposition).

Those statements of two parties as such do not reflect necessarily the common general knowledge of the person skilled in the art if they are not supported by evidence. Furthermore, the argumentations of both opponents were presented to deny that the claimed compounds could be defined by the two most intense peaks of the table, since the intensity depended upon the orientation and grinding. Unless going beyond the intention of the opponents, the board cannot accept in the absence of common general knowledge supporting those declarations that intensity can be totally disregarded.

4.5 Regarding the common general knowledge represented by the documents (3), (4) and (7), the board observes the following:

Document (7) primarily relied upon by the patent proprietor states: "Sample-Sensitive Parameters. These are the most important class of parameters that can affect both the absolute and relative intensity of diffraction lines. Preferred orientation... is the most serious effect and is present to some degree in most specimen mounts".

However, this fact is not relevant since it is well known in the art that the preferred orientation is minimized by the grinding of the specimen (see document (3), page 1844, right-hand column, "Test preparation"). This finding is also confirmed by the patent in suit (see page 5, line 15).

Furthermore, document (3) discloses that the intensity of the diffracted X-ray beam is dependent on several parameters like the intensity and wavelength of the incident radiation or the volume of the crystalline specimen or the absorption of the radiation by the specimen or the experimental arrangement to record the intensity data and concludes "Thus the experimental conditions are especially important for measurement of the diffraction intensities" (see page 1843, right-hand column, third paragraph from the end) emphasizing therefore the importance of these data. It is true that the intensity ratio and the d-spacing can be used to compare an unknown diffraction pattern with a known one (see document (3), page 1844, right-hand column, last paragraph and also document (4), bridging paragraph, pages 189-190). However, this does not necessarily mean that the intensity is not a meaningful parameter when the compound is known - all the more, as document (3) also mentions that "the spacings between and the relative intensities of the diffracted maxima can be used for qualitative and quantitative analysis of crystalline materials" (see page 1843, left-hand column, first paragraph of "X-ray diffraction").

4.6 From the common general knowledge as shown by the documents (3),(4),(7), it cannot be concluded without any doubt, that the relative intensity values are not essential to characterize a crystalline form.

4.7 That means, there is nothing in the description, which could allow the person skilled in the art to derive directly and unambiguously from the application as originally filed that the claimed crystalline form can be characterized by the diffraction values alone.

4.8 In conclusion, the omission of the relative intensity values in claim 1 defines a subject-matter, which has no basis in the description as originally filed.

4.9 The board would like to add that the respondent's contention that the intensity values are not a parameter of the structure of the crystal is incompatible with his response of 8 May 2003 (page 4) where, in order to justify the fact that only two peaks were mentioned in claim 1 as granted, i.e. 19.485 and 21.626, it was stated that "...a man skilled in the crystallographic field is aware that one crystal modification of a known solid material can be sufficiently uniquely characterized by the two most intense 2theta values or by one unique 2theta value of the X-ray powder diffraction pattern measured for said solid material". If that is so, then the values of the relative intensity of each peak are not a parameter which is unrelated with the structure of the crystal.

4.10 It follows that the subject-matter of claim 1 extends beyond the content of the application as originally filed (Article 100(c) EPC).

Late filing of requests

5. Shortly before the end of the oral proceedings the respondent requested to be given the possibility to file auxiliary requests because, so he argued, he had been taken by surprise by the conclusion of the board that the ground of opposition pursuant Article 100(c) EPC was admissible.

5.1 The board refused this request in exercising its discretion conferred on it by Article 13(1) of the Rules of Procedure of the Boards of Appeal of the EPO ("RPBA") in respect of amendments to a party's - here the respondent's - case after it has filed its grounds of appeal or reply. That "discretion shall be exercised in view of inter alia the complexity of the new subject matter submitted, the current state of the proceedings and the need for procedural economy." (Rule 13(1) RPBA). It was clear in the given circumstances, that amended sets of claims, even if they were found to meet the requirements of Article 123(2) EPC (the same requirements as under Article 100(c) EPC), would have had to be examined in respect of all other formal and substantive requirements of the EPC, the board and the opponents not having had the opportunity to prepare themselves for the necessary discussion of all issues raised by amended claims, which were unknown to them and whose filing they didn't expect given the late stage of the proceedings and the respondent's behaviour up to then (cf. Article 13(3) RPBA: "Amendments sought to be made after oral proceedings have been arranged shall not be admitted if they raise issues which the Board or the other party or parties cannot reasonably be expected to deal with without adjournment of the oral proceedings").

5.2 In contrast, the respondent could not reasonably exclude that the issue of the admissibility of an objection pursuant to Article 100(c) EPC would be decided against him, nor was there anything else preventing him from filing amendments in the form of modified or auxiliary requests in time for avoiding their refusal under Article 13(3) RPBA, cited above. The ground of opposition in question was already introduced and discussed before in the first instance proceedings. It was again invoked by the appellant in his statement setting out the grounds of appeal (of 6 August 2006, point 1) and the respondent actually took position on this ground during the written procedure (see letters of 5. March 2007, point 1, and of 29 December 2008, point I). So the respondent had the opportunity to - and actually did - present his comments within the meaning of Article 113(1) EPC on the grounds for the board's decision based on Article 100(c) EPC.

5.3 Under these circumstances the respondent was objectively not taken by surprise and there was no reason exceptionally to admit late amendments in the form of auxiliary requests on that ground.

Order

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.

Footer - Service & support
  • Service & support
    • Website updates
    • Availability of online services
    • FAQ
    • Publications
    • Procedural communications
    • Contact us
    • Subscription centre
    • Official holidays
    • Glossary
Footer - More links
  • Jobs & careers
  • Press centre
  • Single Access Portal
  • Procurement
  • Boards of Appeal
Facebook
European Patent Office
EPO Jobs
Instagram
EuropeanPatentOffice
Linkedin
European Patent Office
EPO Jobs
EPO Procurement
X (formerly Twitter)
EPOorg
EPOjobs
Youtube
TheEPO
Footer
  • Legal notice
  • Terms of use
  • Data protection and privacy
  • Accessibility